Augsburg, Germany

Katharina Kolland

USPTO Granted Patents = 9 

 

Average Co-Inventor Count = 8.8

ph-index = 6

Forward Citations = 149(Granted Patents)


Company Filing History:


Years Active: 2019-2025

Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: Innovator Katharina Kolland: Pioneering Advancements in RNA Technology

Introduction: Katharina Kolland is an accomplished inventor based in Augsburg, Germany, known for her significant contributions to the field of biotechnology. With a total of 9 patents to her name, Kolland has focused her research on the development of innovative methods and formulations involving long-chain RNA, paving the way for potential breakthroughs in pharmaceuticals and vaccines.

Latest Patents: Among her most notable patents is the invention titled "Dry powder composition comprising long-chain RNA." This groundbreaking work is directed towards creating a storage-stable formulation of long-chain RNA. Kolland's invention concerns not only the dry powder composition comprising a long-chain RNA molecule but also methods for preparing such compositions through techniques like spray-drying and spray-freeze drying. The implications of her work extend to the preparation of pharmaceutical compositions and vaccines, providing methods for treating or preventing various disorders and diseases. Additionally, her invention highlights the utility of such compositions in medical applications, leading up to innovative kits that incorporate these formulations.

Career Highlights: Kolland's career is marked by her association with leading biotechnology firms. She has worked at CureVac AG and CureVac SE, contributing her expertise in RNA technology to advance the field. Her dedication and innovative approaches have helped in pushing the boundaries of what is possible in therapeutic applications.

Collaborations: Throughout her career, Katharina Kolland has collaborated with esteemed colleagues, including Fabian Johannes Eber and Thorsten Mutzke. These collaborations have resulted in a dynamic exchange of ideas and expertise, fostering an environment of innovation and discovery.

Conclusion: Katharina Kolland stands out as a significant figure in the realm of biotechnology and RNA research. Her contributions through her inventive patents not only showcase her technical acumen but also underline the importance of collaboration and innovative thinking in scientific progress. As the industry continues to evolve, Kolland's work embodies the spirit of exploration that drives advancements in healthcare and therapeutic solutions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…